醫藥瓶市場 - 全球產業規模、佔有率、趨勢、機會和預測，按瓶子、按應用、按最終用戶、按地區和競爭進行細分，2020-2030F

2024 年全球醫藥瓶市場價值為 73 億美元，預計在預測期內將實現令人印象深刻的成長，到 2030 年的複合年成長率為 3.90%。醫藥瓶是專門用於儲存、保護和分配藥品、疫苗和其他醫療相關物質等藥品的容器。這些瓶子在從製造到患者管理的整個生命週期中對於維護藥物的完整性、安全性和有效性發揮著至關重要的作用。為了防止篡改和未經授權的訪問，藥瓶通常採用防篡改密封、帶或收縮套。這些特徵可以顯示包裹是否已開啟或損壞。藥瓶上貼有標籤，其中包含重要資訊，包括藥品名稱、劑量說明、有效期限、批號和製造商詳細資訊。品牌和標籤對於產品識別和法規遵循至關重要。

主要市場促進因素

技術進步

主要市場挑戰

假冒和產品篡改

主要市場趨勢

永續包裝

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第5章：全球藥瓶市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依瓶子分類（滴管瓶、液體瓶、包裝瓶）
  • 依用途分類（滴管、電子液體、液體、口腔護理）
  • 依最終用戶（化學品、配藥藥房、醫療中心、製藥、藥品包裝）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：亞太地區藥瓶市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 印度
  • 澳洲
  • 日本
  • 韓國

第7章：歐洲藥瓶市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 西班牙
  • 義大利
  • 英國

第 8 章：北美藥瓶市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 墨西哥
  • 加拿大

第9章：南美洲藥瓶市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲藥瓶市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 產品發布
• 合併與收購

第 13 章：全球醫藥瓶市場：SWOT 分析

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 15 章： 大環境分析

第 16 章：競爭格局

• Berry Plastics Global Inc.
• Amcor Plc.
• Schott AG
• West Pharmaceuticals Services Inc.
• Gerresheimer AG
• Aptar Group Inc.
• Nipro Corporation
• Becton & Dickinson CO.
• Westrock Company
• O. Berk Company LLC

第 17 章：策略建議

第18章調查會社について,免責事項

Global Pharmaceutical Bottles Market was valued at USD 7.30 billion in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 3.90% through 2030. Pharmaceutical bottles are specialized containers designed for the storage, protection, and dispensing of pharmaceutical products such as medications, vaccines, and other healthcare-related substances. These bottles play a crucial role in maintaining the integrity, safety, and efficacy of pharmaceutical products throughout their lifecycle, from manufacturing to patient administration. To prevent tampering and unauthorized access, pharmaceutical bottles often incorporate tamper-evident seals, bands, or shrink sleeves. These features indicate if the package has been opened or compromised. Pharmaceutical bottles are labeled with essential information, including the medication name, dosage instructions, expiration date, lot number, and manufacturer details. Branding and labeling are essential for product identification and regulatory compliance.

Key Market Drivers

Technological Advancements

Incorporating RFID (Radio-Frequency Identification) and NFC (Near Field Communication) technology into pharmaceutical bottle caps and labels allows for real-time tracking and monitoring of medication usage. This technology can provide dosage reminders, monitor temperature, and offer tamper-evident features. Advancements in child-resistant packaging technology have led to the development of sophisticated closures that are easy for adults to open but challenging for children. These closures often incorporate features like push-and-turn mechanisms or squeeze-and-turn caps. Tamper-evident seals and features, such as shrink bands and breakable caps, have become more advanced and reliable, ensuring the integrity of pharmaceutical products, and protecting against tampering. Serialization involves the unique identification of each pharmaceutical product and its packaging, typically using 2D barcodes or QR codes. This technology helps in tracking and tracing products throughout the supply chain, reducing the risk of counterfeiting and ensuring product authenticity. High-tech solutions like holograms, color-shifting inks, and specialty printing techniques have been employed to make pharmaceutical bottle labels and packaging resistant to counterfeiting.

Innovations in materials science have led to the development of sustainable packaging materials for pharmaceutical bottles. This includes bio-based plastics, recycled materials, and biodegradable options, reducing the environmental footprint of packaging. To protect the stability of pharmaceutical products, pharmaceutical bottles now come with advanced barrier properties. This helps to maintain the integrity of the contents by preventing moisture, oxygen, and UV light from affecting the medication.

Key Market Challenges

Counterfeiting and Product Tampering

Counterfeit pharmaceutical products can contain incorrect or substandard ingredients, posing serious health risks to patients. Tampered products may be contaminated or otherwise compromised, jeopardizing patient safety. Incidents of counterfeiting and tampering erode trust in pharmaceutical brands and the industry as a whole. Consumers may become wary of purchasing medications, leading to a decrease in patient adherence to prescribed treatments. Pharmaceutical companies are subject to strict regulatory requirements to ensure the safety and authenticity of their products. Failure to prevent counterfeiting and tampering can lead to regulatory non-compliance and legal consequences. The financial implications of counterfeiting and tampering are substantial. Pharmaceutical companies may incur costs related to product recalls, legal actions, and damage control. Additionally, they may experience revenue losses due to reduced sales and damaged brand equity. Incidents of counterfeiting and tampering can disrupt the pharmaceutical supply chain. This can lead to delays in delivering critical medications to patients and healthcare providers, potentially impacting public health during emergencies.

Key Market Trends

Sustainable Packaging

The use of eco-friendly materials for pharmaceutical bottles is on the rise. This includes the development and utilization of bio-based plastics, recycled plastics, and biodegradable materials. These materials reduce the environmental impact of packaging and promote circular economy principles. Sustainable packaging initiatives aim to reduce the use of single-use plastics and minimize plastic waste. Pharmaceutical companies are exploring ways to design bottles that use less plastic while maintaining product integrity and safety. Pharmaceutical bottle manufacturers are designing bottles that are easily recyclable. This encourages recycling efforts and reduces the environmental footprint of pharmaceutical packaging. Lightweight bottle designs are being adopted to reduce transportation costs and energy consumption during shipping. These designs maintain packaging integrity while using fewer resources. Some pharmaceutical companies are exploring reusable and refillable bottle systems, where patients can return empty bottles for refilling. This reduces the need for new packaging and minimizes waste. Sustainable sourcing of materials used in pharmaceutical bottles is a priority. This includes ensuring that raw materials are responsibly and ethically sourced. Sustainable packaging aims to reduce the carbon footprint associated with the production and transportation of pharmaceutical bottles. This is achieved through energy-efficient manufacturing processes and optimizing supply chain logistics. Sustainable packaging must also comply with pharmaceutical regulatory standards to ensure product safety and patient well-being. Growing consumer awareness and demand for sustainable products are pushing pharmaceutical companies to adopt eco-friendly packaging solutions, including sustainable bottles. Many pharmaceutical companies have committed to corporate social responsibility (CSR) initiatives, which include sustainable packaging practices as part of their broader sustainability goals.

Key Market Players

• Berry Plastics Group Inc.
• Amcor Limited
• Gerresheimer AG
• Aptar Pharma
• Westrock Company
• Beckton and Dickinson Co.
• West Pharmaceuticals Services Inc.
• Schott AG
• Nipro Corporation
• O.Berk Company LLC

Report Scope:

In this report, the Global Pharmaceutical Bottles Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Bottles Market, By Bottle:

• Dropper Bottles
• Liquid Bottles
• Packer Bottles

Pharmaceutical Bottles Market, By Application:

• Droppers
• E-Liquid
• Liquid
• Oral Care

Pharmaceutical Bottles Market, By End-User:

• Chemical
• Compounding Pharmacies
• Healthcare Centers
• Pharmaceutical
• Pharmaceutical Packaging

Pharmaceutical Bottles Market, By region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Bottles Market.

Available Customizations:

Global Pharmaceutical Bottles Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Bottles Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Bottle (Dropper Bottles, Liquid Bottles, Packer Bottles)
  • 5.2.2. By Application (Droppers, E-Liquid, Liquid, Oral Care)
  • 5.2.3. By End-User (Chemical, Compounding Pharmacies, Healthcare Centers, Pharmaceutical, Pharmaceutical Packaging)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Pharmaceutical Bottles Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Bottle
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Pharmaceutical Bottles Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Bottle
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. India Pharmaceutical Bottles Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Bottle
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Australia Pharmaceutical Bottles Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Bottle
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User
  • 6.3.4. Japan Pharmaceutical Bottles Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Bottle
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By End User
  • 6.3.5. South Korea Pharmaceutical Bottles Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Bottle
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By End User

7. Europe Pharmaceutical Bottles Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Bottle
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Pharmaceutical Bottles Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Bottle
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Pharmaceutical Bottles Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Bottle
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Spain Pharmaceutical Bottles Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Bottle
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Pharmaceutical Bottles Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Bottle
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. United Kingdom Pharmaceutical Bottles Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Bottle
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. North America Pharmaceutical Bottles Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Bottle
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Pharmaceutical Bottles Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Bottle
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Mexico Pharmaceutical Bottles Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Bottle
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Canada Pharmaceutical Bottles Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Bottle
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User

9. South America Pharmaceutical Bottles Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Bottle
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pharmaceutical Bottles Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Bottle
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Pharmaceutical Bottles Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Bottle
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Pharmaceutical Bottles Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Bottle
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Pharmaceutical Bottles Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Bottle
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pharmaceutical Bottles Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Bottle
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Pharmaceutical Bottles Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Bottle
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Pharmaceutical Bottles Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Bottle
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Pharmaceutical Bottles Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Berry Plastics Global Inc.
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. SWOT Analysis
• 16.2. Amcor Plc.
  • 16.2.1. Business Overview
  • 16.2.2. Company Snapshot
  • 16.2.3. Products & Services
  • 16.2.4. Financials (In case of listed companies)
  • 16.2.5. Recent Developments
  • 16.2.6. SWOT Analysis
• 16.3. Schott AG
  • 16.3.1. Business Overview
  • 16.3.2. Company Snapshot
  • 16.3.3. Products & Services
  • 16.3.4. Financials (In case of listed companies)
  • 16.3.5. Recent Developments
  • 16.3.6. SWOT Analysis
• 16.4. West Pharmaceuticals Services Inc.
  • 16.4.1. Business Overview
  • 16.4.2. Company Snapshot
  • 16.4.3. Products & Services
  • 16.4.4. Financials (In case of listed companies)
  • 16.4.5. Recent Developments
  • 16.4.6. SWOT Analysis
• 16.5. Gerresheimer AG
  • 16.5.1. Business Overview
  • 16.5.2. Company Snapshot
  • 16.5.3. Products & Services
  • 16.5.4. Financials (In case of listed companies)
  • 16.5.5. Recent Developments
  • 16.5.6. SWOT Analysis
• 16.6. Aptar Group Inc.
  • 16.6.1. Business Overview
  • 16.6.2. Company Snapshot
  • 16.6.3. Products & Services
  • 16.6.4. Financials (In case of listed companies)
  • 16.6.5. Recent Developments
  • 16.6.6. SWOT Analysis
• 16.7. Nipro Corporation
  • 16.7.1. Business Overview
  • 16.7.2. Company Snapshot
  • 16.7.3. Products & Services
  • 16.7.4. Financials (In case of listed companies)
  • 16.7.5. Recent Developments
  • 16.7.6. SWOT Analysis
• 16.8. Becton & Dickinson CO.
  • 16.8.1. Business Overview
  • 16.8.2. Company Snapshot
  • 16.8.3. Products & Services
  • 16.8.4. Financials (In case of listed companies)
  • 16.8.5. Recent Developments
  • 16.8.6. SWOT Analysis
• 16.9. Westrock Company
  • 16.9.1. Business Overview
  • 16.9.2. Company Snapshot
  • 16.9.3. Products & Services
  • 16.9.4. Financials (In case of listed companies)
  • 16.9.5. Recent Developments
  • 16.9.6. SWOT Analysis
• 16.10. O. Berk Company LLC
  • 16.10.1. Business Overview
  • 16.10.2. Company Snapshot
  • 16.10.3. Products & Services
  • 16.10.4. Financials (In case of listed companies)
  • 16.10.5. Recent Developments
  • 16.10.6. SWOT Analysis

17. Strategic Recommendations

18. About Us & Disclaimer